TQB3002

· Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for TQB3002, covering 2025-11-25 to 2025-11-25. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Trial of TQB3002 in Patients With Advanced Cancers [Phase 1]